In this guide
What is white willow bark?
Willow bark products use dry bark or young branch bark from Salix species. “White willow” often refers to Salix alba, but Health Canada’s monograph also covers S. daphnoides, S. purpurea and S. × fragilis. Species, plant part and standardization must remain visible. [4]
Salicin is a marker used to standardize extracts and is metabolized through salicylate pathways, but willow bark is not dose-equivalent to aspirin. Evidence is limited to a few short trials, with a signal in low-back pain and null findings in later arthritis trials. [1]–[3]
Typical White Willow Bark Protocols
| Source and context | Material | Amount | Frequency | Duration | Observed result |
|---|---|---|---|---|---|
| Chrubasik 2000 · exacerbation of chronic low-back pain | Oral willow-bark extract | 120 or 240 mg salicin equivalent per day | Daily; within-day frequency not reported in the abstract | 4 weeks | Pain-free without tramadol in final week: 21% low dose, 39% high dose, 6% placebo 210 randomized and 191 completed; tramadol was the sole rescue medicine. One possibly related severe allergic reaction occurred. |
| Biegert 2004 · hip or knee osteoarthritis | Standardized willow-bark extract | 240 mg salicin equivalent per day | Daily; within-day frequency not reported in the abstract | 6 weeks | WOMAC pain did not differ significantly from placebo 127 participants across willow, diclofenac and placebo; willow versus placebo p=0.55. |
| Biegert 2004 · active rheumatoid arthritis | Same standardized extract | 240 mg salicin equivalent per day | Daily; within-day frequency not reported in the abstract | 6 weeks | Pain did not differ significantly from placebo Only 26 participants; willow versus placebo p=0.93. |
There is no established RDA, AI or tolerable upper intake level. A label stating 240 mg of extract does not mean 240 mg of salicin equivalent; the standardization must be stated.
- Titration
- No evidence-based self-titration schedule is established.
- Timing
- Accessible abstracts report daily exposure but not a reliable within-day schedule or meal effect.
- Duration
- The cited trials lasted four to six weeks. NCCIH’s safety summary covers 120–240 mg salicin equivalent daily for up to eight weeks, not indefinite use.
- Stopping
- Stop and seek review for allergy, black or bloody stool, vomiting blood, unusual bruising, ringing in the ears or worsening pain.
Three separate conclusions
Outcome and salicin-equivalent exposure stay attached to each source.
A four-week trial favored 120 and 240 mg/day.
Six-week trials at 240 mg/day were null.
Aspirin sensitivity and bleeding risk remain relevant.
What is white willow bark commonly used for?
Common uses include low-back pain, osteoarthritis, headache, fever and generalized inflammation. The most defensible signal concerns short-term low-back pain; osteoarthritis and rheumatoid-arthritis results are conflicting or null, and evidence does not establish treatment of headache, fever in children or chronic inflammatory disease. [1]–[3]
Which form and label details matter?
Record species, bark or young-branch bark, extract ratio and solvent, milligrams of extract per administration, salicin equivalent per daily amount, number of administrations and lot. Powdered bark, tea and standardized ethanolic extract cannot be converted without composition data.
What does the human evidence show?
Chrubasik 2000 randomized 210 adults with exacerbations of chronic low-back pain; 191 completed. After four weeks, 27 of 65 participants receiving 240 mg/day salicin equivalent, 15 of 67 receiving 120 mg/day and 4 of 59 receiving placebo were pain-free without tramadol for at least five days in the final week. Tramadol was the sole rescue medicine, and one severe allergic reaction was possibly related to the extract. [2]
Biegert 2004 studied 127 people with hip or knee osteoarthritis for six weeks. Willow extract delivering 240 mg/day salicin equivalent reduced WOMAC pain by 8 mm versus 5 mm with placebo; the adjusted difference was not significant (p=0.55). Diclofenac 100 mg/day did differ from placebo. A parallel 26-person rheumatoid-arthritis trial found no significant willow-placebo pain difference (p=0.93). [3]
NCCIH summarizes a 2014 Cochrane review of two trials and 261 participants as moderate-quality evidence for short-term low-back-pain improvement, but also notes a 2019 review that recommended against willow bark for chronic musculoskeletal pain. The small, old and short evidence base does not establish long-term benefit. [1]
How might white willow bark work?
Salicin is converted through salicylate metabolism, while polyphenols and other constituents may contribute. This supports a plausible analgesic pathway but does not make willow bark “natural aspirin,” determine an aspirin-equivalent dose or erase product variability.
What are the risks and interactions?
Gastrointestinal symptoms and allergic reactions are reported. Willow bark may increase bleeding risk, especially with anticoagulants, antiplatelet drugs, NSAIDs, aspirin or other salicylate-containing products. Avoid it with aspirin sensitivity, active ulcer or bleeding disorder, and review use before surgery. [1]
Children and adolescents should avoid willow bark because of Reye-syndrome risk. Pregnancy and breastfeeding are avoidance settings because salicylates cross the placenta and are cleared slowly by newborns. Trial safety in adults for up to eight weeks does not establish safety in these groups or for long-term use. [1]
Get urgent care for trouble breathing, facial or throat swelling, black or bloody stool, vomiting blood, fainting, severe abdominal pain, confusion or uncontrolled bleeding.
Legal status in the United States and Canada
In the United States, willow-bark products may be sold as dietary supplements and are not FDA-approved pain or arthritis treatments.
In Canada, Health Canada’s March 2024 monograph describes an oral product-licensing pathway for dry bark or young-branch bark from four Salix species. It is not a comprehensive evidence review. [4]
What should be monitored?
Record species, extract mass, salicin equivalent, amount per administration, frequency, pain site and scale, function, rescue medicine, bruising, bleeding, gastrointestinal symptoms, allergy and ringing in the ears. Keep other pain treatments visible.
What happens after stopping?
No withdrawal syndrome or taper is established. Pain may return or fluctuate. Persistent or progressive pain needs diagnosis rather than indefinite self-treatment.
How should willow bark be stored?
Follow the label, keep the product dry and sealed away from heat, and retain the lot and expiry date.
Community experience
Community reports often call willow bark “natural aspirin” and mix extract mass with salicin content. They may flag stomach upset or allergy, but cannot establish dose equivalence, efficacy or bleeding safety.
How does white willow bark compare with other approaches?
Exercise, physical therapy, acetaminophen, NSAIDs and condition-specific care have different evidence and risks. Willow bark is not a dosing substitute for aspirin or an NSAID, and severe or neurologic back-pain symptoms require clinical assessment.
Common questions
Is 240 mg salicin the same as 240 mg willow extract?
No. Salicin equivalent and extract mass are different units.
Did the low-back-pain trial allow rescue medicine?
Yes. Tramadol was the sole rescue medicine. [2]
Did it work for osteoarthritis or rheumatoid arthritis?
The six-week trials did not differ significantly from placebo. [3]
Is willow bark natural aspirin?
That phrase hides substantial pharmacologic and dosing differences.
Can children use it for fever?
No. Reye-syndrome risk is a reason to avoid it. [1]
Is it safe in pregnancy?
No. Pregnancy and breastfeeding are avoidance settings. [1]
Can it be combined with aspirin or an anticoagulant?
That may raise bleeding and salicylate exposure and requires clinical review.
Glossary
Terms used in this guide.
- Salicin
- A willow constituent used to standardize some extracts.
- Salicin equivalent
- The amount of salicin represented by a preparation, distinct from total extract mass.
- Salicylate
- A class of compounds related to aspirin pharmacology and safety concerns.
- Reye syndrome
- A rare serious illness associated with salicylate exposure in children during viral illness.
- WOMAC
- A questionnaire measuring osteoarthritis pain, stiffness and function.
- Titration
- Planned dose adjustment; no self-titration schedule is established here.
How this guide was researched
This draft prioritized NCCIH’s clinical digest, the named low-back-pain and arthritis trials and Health Canada’s March 2024 monograph. Evidence was refreshed October 9, 2026.
How this guide was made
The ledger preserves salicin-equivalent units, rescue medicine, null outcomes, within-day frequency limits and safety exclusions.
Research method and gaps
The official NCCIH digest and Health Canada monograph were reviewed directly. Trial details came from PubMed abstracts, so within-day frequency remains unreported where the abstracts provide only a daily total.
Gaps include modern independent replication, long-term safety, product equivalence and clinically important outcomes beyond short pain scales.
Sources
Search the official summary, trials and monograph.
Showing 4 sources
- 01
Nutritional Approaches for Musculoskeletal Pain and Inflammation ↗
Official evidence and safety summary
Short-term low-back-pain evidence with salicylate, bleeding, allergy, pregnancy and pediatric cautions.
- 02
Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. ↗
Randomized double-blind trial
120 or 240 mg salicin equivalent daily for four weeks with tramadol rescue.
- 03
Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. ↗
Two randomized double-blind trials
240 mg salicin equivalent daily for six weeks; both willow-placebo comparisons were nonsignificant.
- 04
Willow Bark Monograph ↗
Natural health product monograph
Covers dry bark or young-branch bark from four Salix species for oral product licensing.
No matching sources
Try a different term or show the full list.